Eric J. Topol

TL;DR: Two dosing schedules of intravenous tissue plasminogen activator (t-PA) for acute myocardial infarction were compared in a multicenter trial and bleeding was reduced in group B patients.

TL;DR: This work advocates greater use of CRP measurements in clinical practice to identify patients at high risk in a variety of situations.

TL;DR: Monoclonal antibodies and snake venom-derived or synthetic peptides directed against a common protein recognition sequence on the platelet glycoprotein IIb/IIIa receptor are currently in the early stages of preclinical and clinical testing and hold promise of preventing abrupt closure and restenosis by inhibiting platelet function.

TL;DR: The presence of proteinuria is the key determinant of risk following PCI for diabetics with and without proteinuria, and Diabetics without evidence ofproteinuria have similar survival compared with nondiabetics.